Amer Bio Medica Stock Net Income
Amer Bio Medica technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Amer Bio's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Amer Bio's valuation are provided below:Amer Bio Medica does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Amer |
Search Suggestions
| AB | AllianceBernstein Holding LP | Company |
| AB | AB | Cryptocurrency |
| ABR-PF | Arbor Realty Trust | Company |
| ABAYX | Abayx | Mutual Fund |
| ABI | VictoryShares Pioneer Asset Based | ETF |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Amer Bio Medica reported net income of (463,000). This is 100.14% lower than that of the Health Care Equipment & Supplies sector and 100.27% lower than that of the Health Care industry. The net income for all United States stocks is 100.08% higher than that of the company.
Amer Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amer Bio's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Amer Bio could also be used in its relative valuation, which is a method of valuing Amer Bio by comparing valuation metrics of similar companies.Amer Bio is currently under evaluation in net income category among its peers.
Amer Fundamentals
| Return On Asset | -0.42 | |||
| Profit Margin | (1.13) % | |||
| Operating Margin | (0.93) % | |||
| Current Valuation | 2.09 M | |||
| Shares Outstanding | 48.1 M | |||
| Shares Owned By Insiders | 31.26 % | |||
| Number Of Shares Shorted | 5.13 K | |||
| Price To Earning | (6.72) X | |||
| Price To Sales | 0.38 X | |||
| Revenue | 2.22 M | |||
| Gross Profit | 548 K | |||
| EBITDA | (199 K) | |||
| Net Income | (463 K) | |||
| Cash And Equivalents | 2 K | |||
| Total Debt | 1.53 M | |||
| Debt To Equity | 0.85 % | |||
| Current Ratio | 0.25 X | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (673 K) | |||
| Short Ratio | 0.09 X | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 32 | |||
| Beta | -0.69 | |||
| Market Capitalization | 480.99 K | |||
| Total Asset | 1.88 M | |||
| Retained Earnings | (21.24 M) | |||
| Working Capital | 937 K | |||
| Current Asset | 2.56 M | |||
| Current Liabilities | 1.62 M | |||
| Z Score | -14.4 | |||
| Net Asset | 1.88 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Amer Pink Sheet
If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |